Literature DB >> 18394840

Identification of a degradation product in stressed tablets of olmesartan medoxomil by the complementary use of HPLC hyphenated techniques.

Tomonori Murakami1, Hidetoshi Konno, Naoto Fukutsu, Michinobu Onodera, Takao Kawasaki, Fumiyo Kusu.   

Abstract

An unknown degradation product (DP-1) increased in olmesartan medoxomil (OLM) tablets stored at 40 degrees C/75% r.h., reaching 0.72% after 6 months. The molecular weight and fragment information obtained by LC-MS suggested that DP-1 was a dehydrated dimer of olmesartan (OL) and the presence of ester carbonyl group was indicated by solvent-elimination LC-IR analysis. LC-(1)H NMR confirmed the structure of DP-1 as an esterified dimer of OL. Rapid and accurate identification of the degradation product was achieved by the complementary use of HPLC hyphenated techniques without complicated isolation or purification processes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18394840     DOI: 10.1016/j.jpba.2008.02.021

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  7 in total

1.  Product development studies on surface-adsorbed nanoemulsion of olmesartan medoxomil as a capsular dosage form.

Authors:  Sumita Singh; Kamla Pathak; Vikas Bali
Journal:  AAPS PharmSciTech       Date:  2012-09-11       Impact factor: 3.246

2.  Multivariate versus classical univariate calibration methods for spectrofluorimetric data: application to simultaneous determination of olmesartan medoxamil and amlodipine besylate in their combined dosage form.

Authors:  Hany W Darwish; Ahmed H Backeit
Journal:  J Fluoresc       Date:  2012-08-16       Impact factor: 2.217

3.  RP-LC and HPTLC Methods for the Determination of Olmesartan Medoxomil and Hydrochlorothiazide in Combined Tablet Dosage Forms.

Authors:  P D Bari; A R Rote
Journal:  Chromatographia       Date:  2009-05-05       Impact factor: 2.044

4.  Spectrophotometric estimation of olmesartan medoxomil and hydrochlorothiazide in tablet.

Authors:  A R Rote; P D Bari
Journal:  Indian J Pharm Sci       Date:  2010-01       Impact factor: 0.975

5.  The application of solid-state NMR spectroscopy to study candesartan cilexetil (TCV-116) membrane interactions. Comparative study with the AT1R antagonist drug olmesartan.

Authors:  Dimitrios Ntountaniotis; Tahsin Kellici; Andreas Tzakos; Pinelopi Kolokotroni; Theodore Tselios; Johanna Becker-Baldus; Clemens Glaubitz; Sonyan Lin; Alexandros Makriyannis; Thomas Mavromoustakos
Journal:  Biochim Biophys Acta       Date:  2014-06-16

6.  Validated Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Azelnidipine and Olmesartan in Their Combined Dosage Form.

Authors:  Jayvadan K Patel; Nilam K Patel
Journal:  Sci Pharm       Date:  2014-02-27

7.  Central Composite Design for Validation of HPTLC Method for Simultaneous Estimation of Olmesartan Medoxomil, Amlodipine Besylate and Hydrochlorothiazide in Tablets.

Authors:  Trupti B Solanki; Purvi A Shah; Kalpana G Patel
Journal:  Indian J Pharm Sci       Date:  2014-05       Impact factor: 0.975

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.